Rakel Óttarsdóttir
Chief Tech/Sci/R&D Officer at ICELANDAIR GROUP HF.
Profile
Rakel Óttarsdóttir is currently the Chief Digital Officer at Icelandair Group hf.
Prior to this, she worked as the Managing Director-Information Technology at Arion Banki HF from 2016 to 2019, and as Vice President at Össur hf.
In 2020, she became the Chief Information Officer at Alvotech hf, where she worked until 2022.
Ms. Óttarsdóttir holds an MBA from Duke University, which she received in 2002, and an undergraduate degree from the University of Iceland, which she received in 1997.
Rakel Óttarsdóttir active positions
| Companies | Position | Start |
|---|---|---|
| ICELANDAIR GROUP HF. | Chief Tech/Sci/R&D Officer | - |
Former positions of Rakel Óttarsdóttir
| Companies | Position | End |
|---|---|---|
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Chief Tech/Sci/R&D Officer | 2022-02-28 |
| ARION BANKI HF. | Chief Tech/Sci/R&D Officer | 2019-09-19 |
| EMBLA MEDICAL HF. | Corporate Officer/Principal | - |
Training of Rakel Óttarsdóttir
| Duke University | Masters Business Admin |
| University of Iceland | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| EMBLA MEDICAL HF. | Health Technology |
| ICELANDAIR GROUP HF. | Transportation |
| ARION BANKI HF. | Finance |
| Private companies | 1 |
|---|---|
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Health Technology |
- Stock Market
- Insiders
- Rakel Óttarsdóttir
